# C_2008040EN.01000501.xml

| 14.2.2008 | EN | Official Journal of the European Union | C 40/5 |
| --- | --- | --- | --- |

14.2.2008

EN

Official Journal of the European Union

C 40/5

---

Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the first half of 2007

(2008/C 40/05)

Subcommittee I — On the free movement of goods

With reference to EEA Joint Committee Decision No 74/1999 of 28 May 1999, the EEA Joint Committee is invited to note the following lists concerning marketing authorisations for medicinal products for the period 1 January-30 June 2007, at their meeting on 28 September 2007:

| ANNEX I | List of new marketing authorisations |
| --- | --- |
| ANNEX II | List of renewed marketing authorisations |
| ANNEX III | List of extended marketing authorisations |
| ANNEX IV | List of withdrawn marketing authorisations |

ANNEX I

List of new marketing authorisations

ANNEX II

List of renewed marketing authorisations

ANNEX III

List of extended marketing authorisations

ANNEX IV

List of withdrawn marketing authorisations

---

ANNEX I

List of new marketing authorisations

The following marketing authorisations have been granted in the EEA EFTA States during the period 1 January-30 June 2007:

| EU-Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/06/001-012/IS | Diacomit | Iceland | 23.1.2007 |
| EU/1/06/343/001-005 | Baraclude | Liechtenstein | 30.4.2007 |
| EU/1/06/360/001-010 | Champix | Liechtenstein | 30.4.2007 |
| EU/1/06/361/001/NO | Luminity | Norway | 7.2.2007 |
| EU/1/06/363/001-009 | Sprycel | Liechtenstein | 30.4.2007 |
| EU/1/06/364/001-005 | Adrovance | Liechtenstein | 28.2.2007 |
| EU/1/06/364/001-005/IS | Adrovance | Iceland | 22.1.2007 |
| EU/1/06/364/001-005/NO | Adrovance | Norway | 14.2.2007 |
| EU/1/06/365/001-003 | Elaprase | Liechtenstein | 28.2.2007 |
| EU/1/06/365/001-003/IS | Elaprase | Iceland | 6.2.2007 |
| EU/1/06/365/001-003/NO | Elaprase | Norway | 30.1.2007 |
| EU/1/06/366/001-004 | Tandemact | Liechtenstein | 28.2.2007 |
| EU/1/06/366/001-004/IS | Tandemact | Iceland | 24.1.2007 |
| EU/1/06/366/001-004/NO | Tandemact | Norway | 30.1.2007 |
| EU/1/06/367/001-012 | Diacomit | Liechtenstein | 28.2.2007 |
| EU/1/06/367/001-012/NO | Diacomit | Norway | 9.2.2007 |
| EU/1/06/368/001-002/IS, 011-019/IS | Insulin Human Winthrop Rapid | Iceland | 15.2.2007 |
| EU/1/06/368/001-002/NO, 011-019/NO | Insulin Human Winthrop Rapid | Norway | 13.2.2007 |
| EU/1/06/368/001-057 | Insulin Human Winthrop | Liechtenstein | 28.2.2007 |
| EU/1/06/368/003-004/IS, 020-028/IS | Insulin Human Winthrop Basal | Iceland | 15.2.2007 |
| EU/1/06/368/003-004/NO, 020-028/NO | Insulin Human Winthrop Basal | Norway | 13.2.2007 |
| EU/1/06/368/005-006/IS, 029-037/IS | Insulin Human Winthrop Comb 15 | Iceland | 15.2.2007 |
| EU/1/06/368/005-006/NO, 029-037/NO | Insulin Human Winthrop Comb 15 | Norway | 13.2.2007 |
| EU/1/06/368/007-008/IS, 038-046/IS | Insulin Human Winthrop Comb 25 | Iceland | 15.2.2007 |
| EU/1/06/368/007-008/NO, 038-046/NO | Insulin Human Winthrop Comb 25 | Norway | 13.2.2007 |
| EU/1/06/368/009-010/IS, 047-055/IS | Insulin Human Winthrop Comb 50 | Iceland | 15.2.2007 |
| EU/1/06/368/009-010/NO, 047-055/NO | Insulin Human Winthrop Comb 50 | Norway | 13.2.2007 |
| EU/1/06/368/056-057/IS | Insulin Human Winthrop Infusat | Iceland | 15.2.2007 |
| EU/1/06/368/056-057/NO | Insulin Human Winthrop Infusat | Norway | 13.2.2007 |
| EU/1/06/369/001-028 | Irbesartan Hydrochlorothiazide BMS | Liechtenstein | 28.2.2007 |
| EU/1/06/369/001-028/IS | Irbesartan HCT BMS | Iceland | 16.2.2007 |
| EU/1/06/369/001-028/NO | Irbesartan HCT BMS | Norway | 15.2.2007 |
| EU/1/06/370/001-024/IS | Exforge | Iceland | 14.2.2007 |
| EU/1/06/370/001-024/NO | Exforge | Norway | 22.2.2007 |
| EU/1/06/371/001-024/IS | Dafiro | Iceland | 14.2.2007 |
| EU/1/06/371/001-024/NO | Dafiro | Norway | 5.3.2007 |
| EU/1/06/372/001-024/IS | Copalia | Iceland | 14.2.2007 |
| EU/1/06/372/001-024/NO | Copalia | Norway | 5.3.2007 |
| EU/1/06/373/001-024/IS | Imprida | Iceland | 14.2.2007 |
| EU/1/06/373/001-024/NO | Imprida | Norway | 5.3.2007 |
| EU/1/06/374/001 | Lucentis | Liechtenstein | 28.2.2007 |
| EU/1/06/374/001/IS | Lucentis | Iceland | 12.2.2007 |
| EU/1/06/374/001/NO | Lucentis | Norway | 7.2.2007 |
| EU/1/06/375/001-033 | Irbesartan BMS | Liechtenstein | 28.2.2007 |
| EU/1/06/375/001-033/IS | Irbesartan BMS | Iceland | 15.2.2007 |
| EU/1/06/375/001-033/NO | Irbesartan BMS | Norway | 15.2.2007 |
| EU/1/06/376/001-033 | Irbesartan Winthrop | Liechtenstein | 28.2.2007 |
| EU/1/06/376/001-033/IS | Irbesartan Winthrop | Iceland | 16.2.2007 |
| EU/1/06/376/001-033/NO | Irbesartan Winthrop | Norway | 15.2.2007 |
| EU/1/06/377/001-028 | Irbesartan Hydrochlorothiazide Winthrop | Liechtenstein | 28.2.2007 |
| EU/1/06/377/001-028/IS | Irbesartan HCT Winthrop | Iceland | 16.2.2007 |
| EU/1/06/377/001-028/NO | Irbesartan HCT Winthrop | Norway | 15.2.2007 |
| EU/1/06/378/001-016 | Inovelon | Liechtenstein | 28.2.2007 |
| EU/1/06/378/001-016/IS | Inovelon | Iceland | 25.2.2007 |
| EU/1/06/378/001-016/NO | Inovelon | Norway | 15.2.2007 |
| EU/1/06/379/001 | Cystadane | Liechtenstein | 28.2.2007 |
| EU/1/06/379/001/IS | Cystadane | Iceland | 23.2.2007 |
| EU/1/06/379/001/NO | Cystadane | Norway | 27.2.2007 |
| EU/1/06/380/001 | Prezista | Liechtenstein | 28.2.2007 |
| EU/1/06/380/001/IS | Prezista | Iceland | 21.2.2007 |
| EU/1/06/380/001/NO | Prezista | Norway | 26.2.2007 |
| EU/1/06/381/001-008 | Daronrix | Liechtenstein | 30.4.2007 |
| EU/1/06/381/001-008/IS | Daronrix | Iceland | 26.3.2007 |
| EU/1/06/381/001-008/NO | Daronrix | Norway | 20.4.2007 |
| EU/1/07/382/001-018 | Xelevia | Liechtenstein | 30.4.2007 |
| EU/1/07/382/001-018/IS | Xelevia | Iceland | 11.4.2007 |
| EU/1/07/382/001-018/NO | Xelevia | Norway | 18.4.2007 |
| EU/1/07/383/001-018 | Januvia | Liechtenstein | 30.4.2007 |
| EU/1/07/383/001-018/IS | Januvia | Iceland | 10.4.2007 |
| EU/1/07/383/001-018/NO | Januvia | Norway | 18.4.2007 |
| EU/1/07/384/001-002 | Docetaxel Winthrop | Liechtenstein | 30.6.2007 |
| EU/1/07/384/001-002/IS | Docetaxel Winthrop | Iceland | 18.5.2007 |
| EU/1/07/384/001-002/NO | Docetaxel Winthrop | Norway | 10.5.2007 |
| EU/1/07/385/001-004 | Focetria | Liechtenstein | 30.6.2007 |
| EU/1/07/385/001-004/IS | Focetria | Iceland | 19.6.2007 |
| EU/1/07/385/001-004/NO | Focetria | Norway | 18.6.2007 |
| EU/1/07/386/001-010 | Toviaz | Liechtenstein | 30.6.2007 |
| EU/1/07/386/001-010/IS | Toviaz | Iceland | 24.5.2007 |
| EU/1/07/386/001-010/NO | Toviaz | Norway | 31.5.2007 |
| EU/1/07/387/001-008 | Advagraf | Liechtenstein | 30.6.2007 |
| EU/1/07/387/001-008/IS | Advagraf | Iceland | 16.5.2007 |
| EU/1/07/387/001-008/NO | Advagraf | Norway | 18.5.2007 |
| EU/1/07/388/001 | Sebivo | Liechtenstein | 30.6.2007 |
| EU/1/07/388/001/IS | Sebivo | Iceland | 24.5.2007 |
| EU/1/07/388/001/NO | Sebivo | Norway | 14.5.2007 |
| EU/1/07/389/001-003 | Orencia | Liechtenstein | 30.6.2007 |
| EU/1/07/389/001-003/IS | Orencia | Iceland | 18.6.2007 |
| EU/1/07/389/001-003/NO | Orencia | Norway | 19.6.2007 |
| EU/1/07/390/001-004 | Altargo | Liechtenstein | 30.6.2007 |
| EU/1/07/390/001-004/IS | Altargo | Iceland | 21.6.2007 |
| EU/1/07/390/001-004/NO | Altargo | Norway | 21.6.2007 |
| EU/1/07/391/001-004 | Revlimid | Liechtenstein | 30.6.2007 |
| EU/1/07/394/001-006 | Optaflu | Liechtenstein | 30.6.2007 |
| EU/1/07/394/001-006/IS | Optaflu | Iceland | 21.6.2007 |
| EU/2/06/064/001-004 | ProMeris | Liechtenstein | 28.2.2007 |
| EU/2/06/064/001-004/IS | ProMeris | Iceland | 18.1.2007 |
| EU/2/06/064/001-004/NO | ProMeris | Norway | 20.2.2007 |
| EU/2/06/065/001-010 | ProMeris Duo | Liechtenstein | 28.2.2007 |
| EU/2/06/065/001-010/IS | ProMeris Duo | Iceland | 18.1.2007 |
| EU/2/06/065/001-010/NO | ProMeris Duo | Norway | 20.2.2007 |
| EU/2/06/066/001-012 | Prac-Tic | Liechtenstein | 28.2.2007 |
| EU/2/06/066/001-012/IS | PRAC-TIC | Iceland | 21.1.2007 |
| EU/2/06/066/001-012/NO | Prac-tic | Norway | 23.1.2007 |
| EU/2/06/067/001-002/IS | Medicinal Oxygen | Iceland | 16.3.2007 |
| EU/2/06/068/001-004 | Ypozane | Liechtenstein | 28.2.2007 |
| EU/2/06/068/001-004/IS | Ypozane | Iceland | 26.1.2007 |
| EU/2/06/068/001-004/NO | Ypozane | Norway | 19.2.2007 |
| EU/2/06/069/001 | Cortavance | Liechtenstein | 28.2.2007 |
| EU/2/06/069/001/IS | Cortavance | Iceland | 23.2.2007 |
| EU/2/06/069/001/NO | Cortavance | Norway | 20.2.2007 |
| EU/2/06/070/001-003 | Meloxicam CEVA | Liechtenstein | 28.2.2007 |
| EU/2/06/070/001-003/NO | Meloxicam Ceva | Norway | 20.2.2007 |
| EU/2/07/071/001-003 | Slentrol | Liechtenstein | 30.6.2007 |
| EU/2/07/071/001-003/IS | Slentrol | Iceland | 26.4.2007 |
| EU/2/07/071/001-003/NO | Slentrol | Norway | 19.6.2007 |
| EU/2/07/073/001-004 | Nobilis Influenza H7N1 | Liechtenstein | 30.6.2007 |
| EU/2/07/073/001-004/IS | Nobilis Influenza H7N1 | Iceland | 1.6.2007 |
| EU/2/07/074/001-006 | Prilactone | Liechtenstein | 30.6.2007 |

EU-Number

Product

Country

Date of authorisation

EU/1/06/001-012/IS

Diacomit

Iceland

23.1.2007

EU/1/06/343/001-005

Baraclude

Liechtenstein

30.4.2007

EU/1/06/360/001-010

Champix

Liechtenstein

30.4.2007

EU/1/06/361/001/NO

Luminity

Norway

7.2.2007

EU/1/06/363/001-009

Sprycel

Liechtenstein

30.4.2007

EU/1/06/364/001-005

Adrovance

Liechtenstein

28.2.2007

EU/1/06/364/001-005/IS

Adrovance

Iceland

22.1.2007

EU/1/06/364/001-005/NO

Adrovance

Norway

14.2.2007

EU/1/06/365/001-003

Elaprase

Liechtenstein

28.2.2007

EU/1/06/365/001-003/IS

Elaprase

Iceland

6.2.2007

EU/1/06/365/001-003/NO

Elaprase

Norway

30.1.2007

EU/1/06/366/001-004

Tandemact

Liechtenstein

28.2.2007

EU/1/06/366/001-004/IS

Tandemact

Iceland

24.1.2007

EU/1/06/366/001-004/NO

Tandemact

Norway

30.1.2007

EU/1/06/367/001-012

Diacomit

Liechtenstein

28.2.2007

EU/1/06/367/001-012/NO

Diacomit

Norway

9.2.2007

EU/1/06/368/001-002/IS, 011-019/IS

Insulin Human Winthrop Rapid

Iceland

15.2.2007

EU/1/06/368/001-002/NO, 011-019/NO

Insulin Human Winthrop Rapid

Norway

13.2.2007

EU/1/06/368/001-057

Insulin Human Winthrop

Liechtenstein

28.2.2007

EU/1/06/368/003-004/IS, 020-028/IS

Insulin Human Winthrop Basal

Iceland

15.2.2007

EU/1/06/368/003-004/NO, 020-028/NO

Insulin Human Winthrop Basal

Norway

13.2.2007

EU/1/06/368/005-006/IS, 029-037/IS

Insulin Human Winthrop Comb 15

Iceland

15.2.2007

EU/1/06/368/005-006/NO, 029-037/NO

Insulin Human Winthrop Comb 15

Norway

13.2.2007

EU/1/06/368/007-008/IS, 038-046/IS

Insulin Human Winthrop Comb 25

Iceland

15.2.2007

EU/1/06/368/007-008/NO, 038-046/NO

Insulin Human Winthrop Comb 25

Norway

13.2.2007

EU/1/06/368/009-010/IS, 047-055/IS

Insulin Human Winthrop Comb 50

Iceland

15.2.2007

EU/1/06/368/009-010/NO, 047-055/NO

Insulin Human Winthrop Comb 50

Norway

13.2.2007

EU/1/06/368/056-057/IS

Insulin Human Winthrop Infusat

Iceland

15.2.2007

EU/1/06/368/056-057/NO

Insulin Human Winthrop Infusat

Norway

13.2.2007

EU/1/06/369/001-028

Irbesartan Hydrochlorothiazide BMS

Liechtenstein

28.2.2007

EU/1/06/369/001-028/IS

Irbesartan HCT BMS

Iceland

16.2.2007

EU/1/06/369/001-028/NO

Irbesartan HCT BMS

Norway

15.2.2007

EU/1/06/370/001-024/IS

Exforge

Iceland

14.2.2007

EU/1/06/370/001-024/NO

Exforge

Norway

22.2.2007

EU/1/06/371/001-024/IS

Dafiro

Iceland

14.2.2007

EU/1/06/371/001-024/NO

Dafiro

Norway

5.3.2007

EU/1/06/372/001-024/IS

Copalia

Iceland

14.2.2007

EU/1/06/372/001-024/NO

Copalia

Norway

5.3.2007

EU/1/06/373/001-024/IS

Imprida

Iceland

14.2.2007

EU/1/06/373/001-024/NO

Imprida

Norway

5.3.2007

EU/1/06/374/001

Lucentis

Liechtenstein

28.2.2007

EU/1/06/374/001/IS

Lucentis

Iceland

12.2.2007

EU/1/06/374/001/NO

Lucentis

Norway

7.2.2007

EU/1/06/375/001-033

Irbesartan BMS

Liechtenstein

28.2.2007

EU/1/06/375/001-033/IS

Irbesartan BMS

Iceland

15.2.2007

EU/1/06/375/001-033/NO

Irbesartan BMS

Norway

15.2.2007

EU/1/06/376/001-033

Irbesartan Winthrop

Liechtenstein

28.2.2007

EU/1/06/376/001-033/IS

Irbesartan Winthrop

Iceland

16.2.2007

EU/1/06/376/001-033/NO

Irbesartan Winthrop

Norway

15.2.2007

EU/1/06/377/001-028

Irbesartan Hydrochlorothiazide Winthrop

Liechtenstein

28.2.2007

EU/1/06/377/001-028/IS

Irbesartan HCT Winthrop

Iceland

16.2.2007

EU/1/06/377/001-028/NO

Irbesartan HCT Winthrop

Norway

15.2.2007

EU/1/06/378/001-016

Inovelon

Liechtenstein

28.2.2007

EU/1/06/378/001-016/IS

Inovelon

Iceland

25.2.2007

EU/1/06/378/001-016/NO

Inovelon

Norway

15.2.2007

EU/1/06/379/001

Cystadane

Liechtenstein

28.2.2007

EU/1/06/379/001/IS

Cystadane

Iceland

23.2.2007

EU/1/06/379/001/NO

Cystadane

Norway

27.2.2007

EU/1/06/380/001

Prezista

Liechtenstein

28.2.2007

EU/1/06/380/001/IS

Prezista

Iceland

21.2.2007

EU/1/06/380/001/NO

Prezista

Norway

26.2.2007

EU/1/06/381/001-008

Daronrix

Liechtenstein

30.4.2007

EU/1/06/381/001-008/IS

Daronrix

Iceland

26.3.2007

EU/1/06/381/001-008/NO

Daronrix

Norway

20.4.2007

EU/1/07/382/001-018

Xelevia

Liechtenstein

30.4.2007

EU/1/07/382/001-018/IS

Xelevia

Iceland

11.4.2007

EU/1/07/382/001-018/NO

Xelevia

Norway

18.4.2007

EU/1/07/383/001-018

Januvia

Liechtenstein

30.4.2007

EU/1/07/383/001-018/IS

Januvia

Iceland

10.4.2007

EU/1/07/383/001-018/NO

Januvia

Norway

18.4.2007

EU/1/07/384/001-002

Docetaxel Winthrop

Liechtenstein

30.6.2007

EU/1/07/384/001-002/IS

Docetaxel Winthrop

Iceland

18.5.2007

EU/1/07/384/001-002/NO

Docetaxel Winthrop

Norway

10.5.2007

EU/1/07/385/001-004

Focetria

Liechtenstein

30.6.2007

EU/1/07/385/001-004/IS

Focetria

Iceland

19.6.2007

EU/1/07/385/001-004/NO

Focetria

Norway

18.6.2007

EU/1/07/386/001-010

Toviaz

Liechtenstein

30.6.2007

EU/1/07/386/001-010/IS

Toviaz

Iceland

24.5.2007

EU/1/07/386/001-010/NO

Toviaz

Norway

31.5.2007

EU/1/07/387/001-008

Advagraf

Liechtenstein

30.6.2007

EU/1/07/387/001-008/IS

Advagraf

Iceland

16.5.2007

EU/1/07/387/001-008/NO

Advagraf

Norway

18.5.2007

EU/1/07/388/001

Sebivo

Liechtenstein

30.6.2007

EU/1/07/388/001/IS

Sebivo

Iceland

24.5.2007

EU/1/07/388/001/NO

Sebivo

Norway

14.5.2007

EU/1/07/389/001-003

Orencia

Liechtenstein

30.6.2007

EU/1/07/389/001-003/IS

Orencia

Iceland

18.6.2007

EU/1/07/389/001-003/NO

Orencia

Norway

19.6.2007

EU/1/07/390/001-004

Altargo

Liechtenstein

30.6.2007

EU/1/07/390/001-004/IS

Altargo

Iceland

21.6.2007

EU/1/07/390/001-004/NO

Altargo

Norway

21.6.2007

EU/1/07/391/001-004

Revlimid

Liechtenstein

30.6.2007

EU/1/07/394/001-006

Optaflu

Liechtenstein

30.6.2007

EU/1/07/394/001-006/IS

Optaflu

Iceland

21.6.2007

EU/2/06/064/001-004

ProMeris

Liechtenstein

28.2.2007

EU/2/06/064/001-004/IS

ProMeris

Iceland

18.1.2007

EU/2/06/064/001-004/NO

ProMeris

Norway

20.2.2007

EU/2/06/065/001-010

ProMeris Duo

Liechtenstein

28.2.2007

EU/2/06/065/001-010/IS

ProMeris Duo

Iceland

18.1.2007

EU/2/06/065/001-010/NO

ProMeris Duo

Norway

20.2.2007

EU/2/06/066/001-012

Prac-Tic

Liechtenstein

28.2.2007

EU/2/06/066/001-012/IS

PRAC-TIC

Iceland

21.1.2007

EU/2/06/066/001-012/NO

Prac-tic

Norway

23.1.2007

EU/2/06/067/001-002/IS

Medicinal Oxygen

Iceland

16.3.2007

EU/2/06/068/001-004

Ypozane

Liechtenstein

28.2.2007

EU/2/06/068/001-004/IS

Ypozane

Iceland

26.1.2007

EU/2/06/068/001-004/NO

Ypozane

Norway

19.2.2007

EU/2/06/069/001

Cortavance

Liechtenstein

28.2.2007

EU/2/06/069/001/IS

Cortavance

Iceland

23.2.2007

EU/2/06/069/001/NO

Cortavance

Norway

20.2.2007

EU/2/06/070/001-003

Meloxicam CEVA

Liechtenstein

28.2.2007

EU/2/06/070/001-003/NO

Meloxicam Ceva

Norway

20.2.2007

EU/2/07/071/001-003

Slentrol

Liechtenstein

30.6.2007

EU/2/07/071/001-003/IS

Slentrol

Iceland

26.4.2007

EU/2/07/071/001-003/NO

Slentrol

Norway

19.6.2007

EU/2/07/073/001-004

Nobilis Influenza H7N1

Liechtenstein

30.6.2007

EU/2/07/073/001-004/IS

Nobilis Influenza H7N1

Iceland

1.6.2007

EU/2/07/074/001-006

Prilactone

Liechtenstein

30.6.2007

---

ANNEX II

List of renewed marketing authorisations

The following marketing authorisations have been renewed in the EEA EFTA States during the period 1 January-30 June 2007:

| EU-Number | Product | Country | Date of renewal |
| --- | --- | --- | --- |
| EU/1/01/200/001 | Viread | Liechtenstein | 28.2.2007 |
| EU/1/01/200/001/IS | Viread | Iceland | 22.1.2007 |
| EU/1/01/200/001/NO | Viread | Norway | 29.1.2007 |
| EU/1/02/201/001-006/IS | Protopic | Iceland | 8.1.2007 |
| EU/1/02/202/001-006/IS | Protopy | Iceland | 8.1.2007 |
| EU/1/02/203/001-004 | Kineret | Liechtenstein | 30.4.2007 |
| EU/1/02/203/001-004/IS | Kineret | Iceland | 22.3.2007 |
| EU/1/02/203/001-004/NO | Kineret | Norway | 18.4.2007 |
| EU/1/02/204/001 | Trisenox | Liechtenstein | 28.2.2007 |
| EU/1/02/204/001/IS | Trisenox | Iceland | 14.3.2007 |
| EU/1/02/204/001/NO | Trisenox | Norway | 22.3.2007 |
| EU/1/02/205/001-002 | Lumigan | Liechtenstein | 30.4.2007 |
| EU/1/02/205/001-002/IS | Lumigan | Iceland | 14.3.2007 |
| EU/1/02/205/001-002/NO | Lumigan | Norway | 29.3.2007 |
| EU/1/02/206/001-020 | Arixtra | Liechtenstein | 30.6.2007 |
| EU/1/02/206/001-020/IS | Arixtra | Iceland | 23.4.2007 |
| EU/1/02/206/001-020/NO | Arixtra | Norway | 18.5.2007 |
| EU/1/02/207/001-020 | Quixidar | Liechtenstein | 30.6.2007 |
| EU/1/02/207/001-020/IS | Quixidar | Iceland | 23.4.2007 |
| EU/1/02/207/001-020/NO | Quixidar | Norway | 18.5.2007 |
| EU/1/02/209/001-008 | Dynastat | Liechtenstein | 30.6.2007 |
| EU/1/02/209/001-008/IS | Dynastat | Iceland | 25.4.2007 |
| EU/1/02/211/001-005 | Dynepo | Liechtenstein | 30.6.2007 |
| EU/1/02/211/001-005, 010-012/IS | Dynepo | Iceland | 25.4.2007 |
| EU/1/02/211/001-005, 010-012/NO | Dynepo | Norway | 18.5.2007 |
| EU/1/02/212/001-026 | Vfend | Liechtenstein | 30.6.2007 |
| EU/1/02/212/001-026/IS | Vfend | Iceland | 16.5.2007 |
| EU/1/02/212/001-026/NO | Vfend | Norway | 23.5.2007 |
| EU/1/02/213/001-016 | MicardisPlus | Liechtenstein | 30.6.2007 |
| EU/1/02/213/001-016/IS | MicardisPlus | Iceland | 23.5.2007 |
| EU/1/02/213/001-016/NO | MicardisPlus | Norway | 18.6.2007 |
| EU/1/02/214/001-010 | Kinzalkomb | Liechtenstein | 30.6.2007 |
| EU/1/02/214/001-010/IS | Kinzalkomb | Iceland | 23.5.2007 |
| EU/1/02/214/001-010/NO | Kinzalkomb | Norway | 18.6.2007 |
| EU/1/02/215/001-014 | PritorPlus | Liechtenstein | 30.6.2007 |
| EU/1/02/215/001-014/IS | PritorPlus | Iceland | 13.6.2007 |
| EU/1/02/215/001-014/NO | PritorPlus | Norway | 18.6.2007 |
| EU/1/02/216/001-002 | Invanz | Liechtenstein | 30.4.2007 |
| EU/1/02/216/001-002/IS | Invanz | Iceland | 21.3.2007 |
| EU/1/02/217/001-002 | Opatanol | Liechtenstein | 30.6.2007 |
| EU/1/02/217/001-002/IS | Opatanol | Iceland | 19.6.2007 |
| EU/1/02/217/001-002/NO | Opatanol | Norway | 28.6.2007 |
| EU/1/02/219/001-015 | Ebixa | Liechtenstein | 30.6.2007 |
| EU/1/02/220/001-005 | Tracleer | Liechtenstein | 30.6.2007 |
| EU/1/02/220/001-005/IS | Tracleer | Iceland | 22.6.2007 |
| EU/1/07/183/001, 004-005, 007-008, 011, 013, 015, 018-029/IS | HBVAXPRO | Iceland | 21.2.2007 |
| EU/1/96/014/001-003/IS | Tritanrix HepH | Iceland | 21.2.2007 |
| EU/1/96/027/001, 003-005/IS | Hycamtin | Iceland | 9.1.2007 |
| EU/1/97/030/028-084 | Insuman | Liechtenstein | 28.2.2007 |
| EU/1/97/030/033-037, 057-58, 69-72/IS | Insuman Basal | Iceland | 16.2.2007 |
| EU/1/97/030/033-037, 057-58, 69-72/NO | Insuman Basal | Norway | 13.2.2007 |
| EU/1/97/030/038-042, 59-60, 73-76/IS | Insuman Comb 15 | Iceland | 16.2.2007 |
| EU/1/97/030/038-042, 59-60, 73-76/NO | Insuman Comb 15 | Norway | 13.2.2007 |
| EU/1/97/030/043-047, 61-62, 77-80/IS | Insuman Comb 25 | Iceland | 16.2.2007 |
| EU/1/97/030/043-047, 61-62, 77-80/NO | Insuman Comb 25 | Norway | 13.2.2007 |
| EU/1/97/030/048-052, 63-64, 81-84/IS | Insuman Comb 50 | Iceland | 16.2.2007 |
| EU/1/97/030/048-052, 63-64, 81-84/NO | Insuman Comb 50 | Norway | 13.2.2007 |
| EU/1/97/030/053-054/IS | Insuman Comb Infusat | Iceland | 16.2.2007 |
| EU/1/97/030/053-054/NO | Insuman Comb Infusat | Norway | 13.2.2007 |
| EU/1/97/030/28-32, 55-56, 65-68/IS | Insuman Rapid | Iceland | 16.2.2007 |
| EU/1/97/030/28-32, 55-56, 65-68/NO | Insuman Rapid | Norway | 13.2.2007 |
| EU/1/97/032/001 | Leukoscan | Liechtenstein | 30.6.2007 |
| EU/1/97/032/001/IS | Leukoscan | Iceland | 27.6.2007 |
| EU/1/97/033/001-003 | Avonex | Liechtenstein | 30.4.2007 |
| EU/1/97/033/001-003/IS | Avonex | Iceland | 13.3.2007 |
| EU/1/97/033/001-003/NO | Avonex | Norway | 20.3.2007 |
| EU/1/97/035/001-004 | Refludan | Liechtenstein | 30.4.2007 |
| EU/1/97/035/001-004/IS | Refludan | Iceland | 14.3.2007 |
| EU/1/97/035/001-004/NO | Refludan | Norway | 10.4.2007 |
| EU/1/97/037/001 | Vistide | Liechtenstein | 30.6.2007 |
| EU/1/97/040/001-002 | Teslascan | Liechtenstein | 30.6.2007 |
| EU/1/97/040/001-002/IS | Teslascan | Iceland | 19.6.2007 |
| EU/2/01/030/001-004/NO | Virbagen Omega | Norway | 14.3.2007 |
| EU/2/02/032/001 | Vaxxitek HVT+IBD | Liechtenstein | 30.6.2007 |
| EU/2/96/002/001-003 | Fevaxyn Pentofel | Liechtenstein | 30.4.2007 |
| EU/2/96/002/001-003/IS | Fevaxyn Pentofel | Iceland | 14.3.2007 |

EU-Number

Product

Country

Date of renewal

EU/1/01/200/001

Viread

Liechtenstein

28.2.2007

EU/1/01/200/001/IS

Viread

Iceland

22.1.2007

EU/1/01/200/001/NO

Viread

Norway

29.1.2007

EU/1/02/201/001-006/IS

Protopic

Iceland

8.1.2007

EU/1/02/202/001-006/IS

Protopy

Iceland

8.1.2007

EU/1/02/203/001-004

Kineret

Liechtenstein

30.4.2007

EU/1/02/203/001-004/IS

Kineret

Iceland

22.3.2007

EU/1/02/203/001-004/NO

Kineret

Norway

18.4.2007

EU/1/02/204/001

Trisenox

Liechtenstein

28.2.2007

EU/1/02/204/001/IS

Trisenox

Iceland

14.3.2007

EU/1/02/204/001/NO

Trisenox

Norway

22.3.2007

EU/1/02/205/001-002

Lumigan

Liechtenstein

30.4.2007

EU/1/02/205/001-002/IS

Lumigan

Iceland

14.3.2007

EU/1/02/205/001-002/NO

Lumigan

Norway

29.3.2007

EU/1/02/206/001-020

Arixtra

Liechtenstein

30.6.2007

EU/1/02/206/001-020/IS

Arixtra

Iceland

23.4.2007

EU/1/02/206/001-020/NO

Arixtra

Norway

18.5.2007

EU/1/02/207/001-020

Quixidar

Liechtenstein

30.6.2007

EU/1/02/207/001-020/IS

Quixidar

Iceland

23.4.2007

EU/1/02/207/001-020/NO

Quixidar

Norway

18.5.2007

EU/1/02/209/001-008

Dynastat

Liechtenstein

30.6.2007

EU/1/02/209/001-008/IS

Dynastat

Iceland

25.4.2007

EU/1/02/211/001-005

Dynepo

Liechtenstein

30.6.2007

EU/1/02/211/001-005, 010-012/IS

Dynepo

Iceland

25.4.2007

EU/1/02/211/001-005, 010-012/NO

Dynepo

Norway

18.5.2007

EU/1/02/212/001-026

Vfend

Liechtenstein

30.6.2007

EU/1/02/212/001-026/IS

Vfend

Iceland

16.5.2007

EU/1/02/212/001-026/NO

Vfend

Norway

23.5.2007

EU/1/02/213/001-016

MicardisPlus

Liechtenstein

30.6.2007

EU/1/02/213/001-016/IS

MicardisPlus

Iceland

23.5.2007

EU/1/02/213/001-016/NO

MicardisPlus

Norway

18.6.2007

EU/1/02/214/001-010

Kinzalkomb

Liechtenstein

30.6.2007

EU/1/02/214/001-010/IS

Kinzalkomb

Iceland

23.5.2007

EU/1/02/214/001-010/NO

Kinzalkomb

Norway

18.6.2007

EU/1/02/215/001-014

PritorPlus

Liechtenstein

30.6.2007

EU/1/02/215/001-014/IS

PritorPlus

Iceland

13.6.2007

EU/1/02/215/001-014/NO

PritorPlus

Norway

18.6.2007

EU/1/02/216/001-002

Invanz

Liechtenstein

30.4.2007

EU/1/02/216/001-002/IS

Invanz

Iceland

21.3.2007

EU/1/02/217/001-002

Opatanol

Liechtenstein

30.6.2007

EU/1/02/217/001-002/IS

Opatanol

Iceland

19.6.2007

EU/1/02/217/001-002/NO

Opatanol

Norway

28.6.2007

EU/1/02/219/001-015

Ebixa

Liechtenstein

30.6.2007

EU/1/02/220/001-005

Tracleer

Liechtenstein

30.6.2007

EU/1/02/220/001-005/IS

Tracleer

Iceland

22.6.2007

EU/1/07/183/001, 004-005, 007-008, 011, 013, 015, 018-029/IS

HBVAXPRO

Iceland

21.2.2007

EU/1/96/014/001-003/IS

Tritanrix HepH

Iceland

21.2.2007

EU/1/96/027/001, 003-005/IS

Hycamtin

Iceland

9.1.2007

EU/1/97/030/028-084

Insuman

Liechtenstein

28.2.2007

EU/1/97/030/033-037, 057-58, 69-72/IS

Insuman Basal

Iceland

16.2.2007

EU/1/97/030/033-037, 057-58, 69-72/NO

Insuman Basal

Norway

13.2.2007

EU/1/97/030/038-042, 59-60, 73-76/IS

Insuman Comb 15

Iceland

16.2.2007

EU/1/97/030/038-042, 59-60, 73-76/NO

Insuman Comb 15

Norway

13.2.2007

EU/1/97/030/043-047, 61-62, 77-80/IS

Insuman Comb 25

Iceland

16.2.2007

EU/1/97/030/043-047, 61-62, 77-80/NO

Insuman Comb 25

Norway

13.2.2007

EU/1/97/030/048-052, 63-64, 81-84/IS

Insuman Comb 50

Iceland

16.2.2007

EU/1/97/030/048-052, 63-64, 81-84/NO

Insuman Comb 50

Norway

13.2.2007

EU/1/97/030/053-054/IS

Insuman Comb Infusat

Iceland

16.2.2007

EU/1/97/030/053-054/NO

Insuman Comb Infusat

Norway

13.2.2007

EU/1/97/030/28-32, 55-56, 65-68/IS

Insuman Rapid

Iceland

16.2.2007

EU/1/97/030/28-32, 55-56, 65-68/NO

Insuman Rapid

Norway

13.2.2007

EU/1/97/032/001

Leukoscan

Liechtenstein

30.6.2007

EU/1/97/032/001/IS

Leukoscan

Iceland

27.6.2007

EU/1/97/033/001-003

Avonex

Liechtenstein

30.4.2007

EU/1/97/033/001-003/IS

Avonex

Iceland

13.3.2007

EU/1/97/033/001-003/NO

Avonex

Norway

20.3.2007

EU/1/97/035/001-004

Refludan

Liechtenstein

30.4.2007

EU/1/97/035/001-004/IS

Refludan

Iceland

14.3.2007

EU/1/97/035/001-004/NO

Refludan

Norway

10.4.2007

EU/1/97/037/001

Vistide

Liechtenstein

30.6.2007

EU/1/97/040/001-002

Teslascan

Liechtenstein

30.6.2007

EU/1/97/040/001-002/IS

Teslascan

Iceland

19.6.2007

EU/2/01/030/001-004/NO

Virbagen Omega

Norway

14.3.2007

EU/2/02/032/001

Vaxxitek HVT+IBD

Liechtenstein

30.6.2007

EU/2/96/002/001-003

Fevaxyn Pentofel

Liechtenstein

30.4.2007

EU/2/96/002/001-003/IS

Fevaxyn Pentofel

Iceland

14.3.2007

---

ANNEX III

List of extended marketing authorisations

The following marketing authorisations have been extended in the EEA EFTA States during the period 1 January-30 June 2007:

| EU-Number | Product | Country | Date of extention |
| --- | --- | --- | --- |
| EU/1/00/134/030-037 | Lantus | Liechtenstein | 28.2.2007 |
| EU/1/00/157/035-067 | Azomyr | Liechtenstein | 30.6.2007 |
| EU/1/00/157/035-067/IS | Azomyr | Iceland | 22.5.2007 |
| EU/1/00/157/035-067/NO | Azomyr | Norway | 5.6.2007 |
| EU/1/00/160/037-069 | Aerius | Liechtenstein | 30.6.2007 |
| EU/1/00/160/037-069/IS | Aerius | Iceland | 22.5.2007 |
| EU/1/00/160/037-069/NO | Aerius | Norway | 5.6.2007 |
| EU/1/00/161/035/067/IS | Neoclarityn | Iceland | 22.5.2007 |
| EU/1/00/161/035-067 | Neoclarityn | Liechtenstein | 30.6.2007 |
| EU/1/00/161/035-067/NO | Neoclarityn | Norway | 5.6.2007 |
| EU/1/01/184/069-073 | Nespo | Liechtenstein | 30.6.2007 |
| EU/1/01/184/069-073/IS | Nespo | Iceland | 1.6.2007 |
| EU/1/01/185/069-073 | Aranesp | Liechtenstein | 30.6.2007 |
| EU/1/01/185/069-073/IS | Aranesp | Iceland | 25.5.2007 |
| EU/1/02/211/010-012 | Dynepo | Liechtenstein | 30.4.2007 |
| EU/1/02/213/013-016 | MicardisPlus | Liechtenstein | 28.2.2007 |
| EU/1/02/215/013-014 | PritorPlus | Liechtenstein | 28.2.2007 |
| EU/1/03/251/002 | Hepsera | Liechtenstein | 30.6.2007 |
| EU/1/03/266/005-006 | Bondenza | Liechtenstein | 30.4.2007 |
| EU/1/04/276/036/IS | Abilify | Iceland | 18.1.2007 |
| EU/1/04/280/008 | Yentreve | Liechtenstein | 30.4.2007 |
| EU/1/04/281/002-005 | Erbitux | Liechtenstein | 30.4.2007 |
| EU/1/04/281/002-005/IS | Erbitux | Iceland | 21.2.2007 |
| EU/1/04/281/002-005/NO | Erbitux | Norway | 14.3.2007 |
| EU/1/04/307/011-013 | Zonegran | Liechtenstein | 30.4.2007 |
| EU/1/05/327/018 | Exubera | Liechtenstein | 30.4.2007 |
| EU/1/05/331/014-037 | Ne juin upro | Liechtenstein | 28.2.2007 |
| EU/1/06/332/004-006 | Omnitrope | Liechtenstein | 30.6.2007 |
| EU/1/06/332/004-006/IS | Omnitrope | Iceland | 18.5.2007 |
| EU/1/06/349/009-010 | Avaglim | Liechtenstein | 30.6.2007 |
| EU/1/06/360/011 | Champix | Liechtenstein | 30.6.2007 |
| EU/1/96/016/004 | Norvir | Liechtenstein | 28.2.2007 |
| EU/1/98/069/005a, 005b, 006a, 006b | Plavix | Liechtenstein | 30.6.2007 |
| EU/1/98/070/005a, 005b, 006a, 006b | Iscover | Liechtenstein | 30.6.2007 |
| EU/1/98/089/020-022 | Pritor | Liechtenstein | 28.2.2007 |
| EU/1/98/090/017-020 | Micardis | Liechtenstein | 28.2.2007 |
| EU/1/98/096/009-012 | Temodal | Liechtenstein | 30.6.2007 |
| EU/1/98/096/009-012/IS | Temodal | Iceland | 22.5.2007 |
| EU/1/98/096/009-012/NO | Temodal | Norway | 29.5.2007 |
| EU/1/99/111/010-011/NO | Stocrin | Norway | 8.1.2007 |
| EU/1/99/123/012 | Renagel | Liechtenstein | 30.6.2007 |
| EU/2/03/040/002 | Gonazon | Liechtenstein | 28.2.2007 |
| EU/2/03/040/002/IS | Gonazon | Iceland | 29.1.2007 |
| EU/2/03/040/002/NO | Gonazon | Norway | 20.2.2007 |
| EU/2/04/044/006 | Aivlosin | Liechtenstein | 30.4.2007 |
| EU/2/04/045/005-006 | Previcox | Liechtenstein | 28.2.2007 |
| EU/2/04/045/007 | Previcox | Liechtenstein | 30.4.2007 |
| EU/2/04/045/007/IS | Previcox | Iceland | 21.3.2007 |
| EU/2/97/004/024-025 | Metacam | Liechtenstein | 30.4.2007 |
| EU/2/97/004/026-028 | Metacam | Liechtenstein | 30.6.2007 |

EU-Number

Product

Country

Date of extention

EU/1/00/134/030-037

Lantus

Liechtenstein

28.2.2007

EU/1/00/157/035-067

Azomyr

Liechtenstein

30.6.2007

EU/1/00/157/035-067/IS

Azomyr

Iceland

22.5.2007

EU/1/00/157/035-067/NO

Azomyr

Norway

5.6.2007

EU/1/00/160/037-069

Aerius

Liechtenstein

30.6.2007

EU/1/00/160/037-069/IS

Aerius

Iceland

22.5.2007

EU/1/00/160/037-069/NO

Aerius

Norway

5.6.2007

EU/1/00/161/035/067/IS

Neoclarityn

Iceland

22.5.2007

EU/1/00/161/035-067

Neoclarityn

Liechtenstein

30.6.2007

EU/1/00/161/035-067/NO

Neoclarityn

Norway

5.6.2007

EU/1/01/184/069-073

Nespo

Liechtenstein

30.6.2007

EU/1/01/184/069-073/IS

Nespo

Iceland

1.6.2007

EU/1/01/185/069-073

Aranesp

Liechtenstein

30.6.2007

EU/1/01/185/069-073/IS

Aranesp

Iceland

25.5.2007

EU/1/02/211/010-012

Dynepo

Liechtenstein

30.4.2007

EU/1/02/213/013-016

MicardisPlus

Liechtenstein

28.2.2007

EU/1/02/215/013-014

PritorPlus

Liechtenstein

28.2.2007

EU/1/03/251/002

Hepsera

Liechtenstein

30.6.2007

EU/1/03/266/005-006

Bondenza

Liechtenstein

30.4.2007

EU/1/04/276/036/IS

Abilify

Iceland

18.1.2007

EU/1/04/280/008

Yentreve

Liechtenstein

30.4.2007

EU/1/04/281/002-005

Erbitux

Liechtenstein

30.4.2007

EU/1/04/281/002-005/IS

Erbitux

Iceland

21.2.2007

EU/1/04/281/002-005/NO

Erbitux

Norway

14.3.2007

EU/1/04/307/011-013

Zonegran

Liechtenstein

30.4.2007

EU/1/05/327/018

Exubera

Liechtenstein

30.4.2007

EU/1/05/331/014-037

Ne juin upro

Liechtenstein

28.2.2007

EU/1/06/332/004-006

Omnitrope

Liechtenstein

30.6.2007

EU/1/06/332/004-006/IS

Omnitrope

Iceland

18.5.2007

EU/1/06/349/009-010

Avaglim

Liechtenstein

30.6.2007

EU/1/06/360/011

Champix

Liechtenstein

30.6.2007

EU/1/96/016/004

Norvir

Liechtenstein

28.2.2007

EU/1/98/069/005a, 005b, 006a, 006b

Plavix

Liechtenstein

30.6.2007

EU/1/98/070/005a, 005b, 006a, 006b

Iscover

Liechtenstein

30.6.2007

EU/1/98/089/020-022

Pritor

Liechtenstein

28.2.2007

EU/1/98/090/017-020

Micardis

Liechtenstein

28.2.2007

EU/1/98/096/009-012

Temodal

Liechtenstein

30.6.2007

EU/1/98/096/009-012/IS

Temodal

Iceland

22.5.2007

EU/1/98/096/009-012/NO

Temodal

Norway

29.5.2007

EU/1/99/111/010-011/NO

Stocrin

Norway

8.1.2007

EU/1/99/123/012

Renagel

Liechtenstein

30.6.2007

EU/2/03/040/002

Gonazon

Liechtenstein

28.2.2007

EU/2/03/040/002/IS

Gonazon

Iceland

29.1.2007

EU/2/03/040/002/NO

Gonazon

Norway

20.2.2007

EU/2/04/044/006

Aivlosin

Liechtenstein

30.4.2007

EU/2/04/045/005-006

Previcox

Liechtenstein

28.2.2007

EU/2/04/045/007

Previcox

Liechtenstein

30.4.2007

EU/2/04/045/007/IS

Previcox

Iceland

21.3.2007

EU/2/97/004/024-025

Metacam

Liechtenstein

30.4.2007

EU/2/97/004/026-028

Metacam

Liechtenstein

30.6.2007

---

ANNEX IV

List of withdrawn marketing authorisations

The following marketing authorisations have been withdrawn in the EEA EFTA States during the period 1 January-30 June 2007:

| EU-Number | Product | Country | Date of withdrawal |
| --- | --- | --- | --- |
| EU/1/02/236/001-004/IS | Ultratard | Iceland | 1.1.2007 |
| EU/1/02/235/001-004/IS | Monotard | Iceland | 1.1.2007 |

EU-Number

Product

Country

Date of withdrawal

EU/1/02/236/001-004/IS

Ultratard

Iceland

1.1.2007

EU/1/02/235/001-004/IS

Monotard

Iceland

1.1.2007

---